Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • BG Medicine, Inc. (BGMD) Names Dr. Paul Sohmer As New CEO 0 comments
    May 9, 2013 2:18 PM | about stocks: BGMD

    BG Medicine is a diagnostics company focused on the development and commercialization of novel cardiovascular tests. The company has two products: the Galectin-3 test for use in patients with chronic heart failure and the CardioSCORE test for the risk prediction of major cardiovascular events.

    The company announced today that it has appointed Paul Sohmer, M.D., as its president and chief executive officer and a member of its Board of Directors. He replaces Eric Bouvier as CEO. Dr. Sohmer brings more than 25 years of experience leading the growth of commercial-stage companies focused on diagnostics, laboratory services, and medical devices.

    Dr. Sohmer most recently served as president and CEO of Viracor-IBT Laboratories, a diagnostic and research laboratory specializing in allergy, immunology, and infectious disease testing. Prior to that, he was CEO of Orthocon, a developer, manufacturer, and marketer of implantable medical products. Sohmer also has served as interim CEO of Cylex and CEO of Pathway Diagnostics.

    In addition, Dr. Sohmer was president and CEO of Neuromedical Systems before its acquisition by TriPath Imaging. He then became TriPath's chairman, president, and CEO before it was acquired by the giant medical technology company Becton, Dickinson. Earlier in his career, Sohmer served as president and CEO of Genetrix, a genetic testing lab that was acquired by Genzyme.

    Dr. Sohmer said, "Our challenge now is to unlock the clinical and commercial potential of the company's innovative diagnostic tests. Going forward we will work to enhance and leverage our assets to create a commercial engine that will allow us to grow and drive our margin."

    For additional information about BG Medicine and its two innovative diagnostic tests, please visit bg-medicine.com

    About QualityStocks

    QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

    Sign up for "The QualityStocks Daily Newsletter" at QualityStocks.net

    The Quality Stocks Daily Blog blog.qualitystocks.net

    The Quality Stocks Daily Videos videocharts.qualitystocks.net

    The Quality Stocks "Ones to Watch" gotstocks.qualitystocks.net

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: BGMD
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.